Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients
ContributorsMottier, Dominique; Girard, Philippe; Couturaud, Francis; Lacut, Karine; Le Moigne, Emmanuelle; Paleiron, Nicolas; Guellec, Dewi; Sanchez, Olivier; Cogulet, Virginie; Laporte, Silvy; Marhic, Gisèle; Mismetti, Patrick; Presles, Emilie; Robert-Ebadi, Helia; Mahé, Isabelle; Plaisance, Ludovic; Reny, Jean-Luc
; Darbellay, Pauline; Cuvelier, Clémence; Le Henaff, Catherine; Lambert, Yannick; Danguy des Deserts, Marc; Rousseau Legrand, Claire; Boutreux, Sébastien; Bleher, Yves; Decours, Romain; Trinh-Duc, Albert; Armengol, Guillaume; Benhamou, Ygal; Daumas, Aurélie; Guyot, Sarah-Lou; De Carvalho, Hugo; Lamia, Bouchra; Righini, Marc Philip
; Meyer, Guy; Le Gal, Grégoire
Published inNEJM evidence, vol. 2, no. 8, EVIDoa2200332
Publication date2023-08
First online date2023-06-27
Abstract
Keywords
- Aged
- Humans
- Anticoagulants
- Enoxaparin
- Patients
- Venous Thromboembolism / drug therapy
Citation (ISO format)
MOTTIER, Dominique et al. Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients. In: NEJM evidence, 2023, vol. 2, n° 8, p. EVIDoa2200332. doi: 10.1056/EVIDoa2200332
Main files (1)
Article (Published version)
Identifiers
- PID : unige:176421
- DOI : 10.1056/EVIDoa2200332
- PMID : 38320142
Additional URL for this publicationhttps://evidence.nejm.org/doi/10.1056/EVIDoa2200332
Journal ISSN2766-5526